News About: Pharm. Industry
Pharmaceutical companies to rush founding new factories, “Targeting the global market”
Domestic pharmaceutical companies have actively started to invest funds on manufacturing facilities. The purpose of the investment is to secure capability to expand their products into the global market.
In fact, all...
Green Cross Labcell starts world’s first commercialization of NK cell treatmentAn anticancer therapy, which uses other healthy people’s immune cells not the ones of cancer patients, is expected to be commercialized within in a couple of years for the first...
|
‘3rd Global Pharmaceutical Fund’ to be completed late January
Development of the ‘3rd Global Pharmaceutical Fund,’ which will become the base of the pharmaceutical and medical package expansion, is expected to be completed late January.
In order to support the foreign expansion...
Domestic supply of GSK’s meningitis, ‘Hiberix,’ suspended‘Hiberix,’ a meningitis vaccine, has been suspended in the domestic supply.
GSK, the supplier of the drug, decided to suspend the supply of Hiberix as adopting ‘Vaxem-Hib,’ ano...
|
Will Boehringer give Yuhan Corporation ‘Jardiance’?
As ‘Jardiance(generic name: empagliflozin),’ a SGLT-2 inhibitor, is anticipated to receive the insurance benefit in the 1st half of the year at the latest, the industry has paid attention on which company will become ...
Bayer’s labor union begins limitless one-person protestThe Bayer’s labor union has begun a no-time-limit one-person protest over the recommended resignation of the 3 team managers in the women health department.
Since the company h...
|
77 pharmaceutical products including multinational ones liquidates 531 products
Multinational pharmaceutical companies, as well as domestic ones, have decided to voluntarily liquidate pharmaceutical products weakened in market competitiveness.
According to the Ministry of Food and Drug Safety, 7...
CEOs of domestic pharmaceutical companies left to the U.S., “To become the next Hanmi”
CEOs and researchers of major domestic pharmaceutical companies left the country to participate in the J.P. Morgan Healthcare Conference which will be held for five days between the 11th and 14th in San Francisco.
Al...
AZ rejected on the Seroquel’s flexible application of PMS cases for children
The flexible application of the post-marketing surveillance(PMS) for the AstraZeneca’s schizophrenia treatment, ‘Seroquel(generic name: quetiapine),’ was rejected. The issue was the number of cases targeting children ...
Dong-A Pharm’s Bacchus exceeds KRW 200 billion annual sales as single productCreating a term, ‘Bacchus Legend,’ Dong-A Pharm(President and CEO Won-hee Lee) announced on the 11th that the domestic sales of ‘Bacchus,’ which has become the leading energy dr...
|
